I wonder how far this share can go?This is a little old but I...

I wonder how far this share can go?

This is a little old but I gleaned it from
http://microtrader.com.au/post/13448469754/tissue-therapies-announces-commercialisation-strategy

Assume, TIS can earn 20% after expenses on the targeted $1bn pa of sales. That’s $200m and would value the company at $1.5 - $2bn, a comfortable 18 - 24x the current share price. However, the company would likely become a take over target well before then.

And this was in november when price was stronger I think